At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 13, 2026 at 16:11 ET
Affinity Asset Advisors filed an amended Schedule 13G disclosing a 4.1% passive stake in Equillium as of September 30, 2026, representing 2,613,954 shares. This is a new passive disclosure below the 5% threshold, with no change in investment intent indicated.
- Affinity Asset Advisors disclosed beneficial ownership of 2,613,954 shares of Equillium common stock as of September 30, 2026
- Stake represents approximately 4.1% of shares outstanding based on 63,408,082 shares outstanding as of August 7, 2026
- Filing is an amendment to Schedule 13G, confirming passive investment intent
- Shares are held directly by Affinity Healthcare Fund, LP, with Affinity Asset Advisors as investment manager
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access